Want to join the conversation?
$PRGO received U.S. FDA approval for generic version of Upsher-Smith Labs' KlorCon (potassium chloride) extended-release tablets (600 mg & 750 mg), which are marketed by $NVS. KlorCon is indicated for treatment of hypokalemia (low levels of potassium in blood). The U.S. market for the both generic and branded offerings of KlorCon is about $81MM.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.